STUDY OBJECTIVES: Although the sentinel lymph node (SLN) concept has traditionally been applied to solid organs, we hypothesized that the pleural space might drain into a specific SLN group. The identification of such a nodal group could assist in the staging and treatment of pleural-based diseases, such as mesothelioma, or other lung cancers with visceral pleural invasion. The purpose of this study was to determine whether the pleural space has an SLN group. DESIGN: Sixteen rats underwent right or left pleural space injection of a novel lymph tracer, quantum dots (QDs), which have a hydrodynamic diameter of 15 nm and fluoresce in the near-infrared (NIR) spectrum. Nodal uptake of the entire thorax was imaged with a custom system that simultaneously acquired color video, NIR fluorescence of the QDs, and a merged picture of the two in real-time. Six pigs underwent right or left pleural space injection of QDs and similar imaging. MEASUREMENTS AND RESULTS: In the rat, the QDs drained solely to the highest superior mediastinal lymph node group, corresponding to lymph node station 1, according the regional lymph node classification for lung of the American Joint Committee on Cancer. In one rat, the injection of QDs in the left pleural space resulted in migration to the contralateral station 1 lymph node group. The injection of QDs in the right or left pleural space of the pig resulted in migration solely to the ipsilateral highest superior mediastinal lymph node group. CONCLUSIONS: NIR fluorescence imaging in two species demonstrated that the highest superior mediastinal lymph nodes of station 1 are the SLNs of the pleural space. This study also provides intraoperative feasibility and proof of the concept for identifying lymph nodes communicating with the pleural space on a patient-specific basis, in real-time, and with high sensitivity.
STUDY OBJECTIVES: Although the sentinel lymph node (SLN) concept has traditionally been applied to solid organs, we hypothesized that the pleural space might drain into a specific SLN group. The identification of such a nodal group could assist in the staging and treatment of pleural-based diseases, such as mesothelioma, or other lung cancers with visceral pleural invasion. The purpose of this study was to determine whether the pleural space has an SLN group. DESIGN: Sixteen rats underwent right or left pleural space injection of a novel lymph tracer, quantum dots (QDs), which have a hydrodynamic diameter of 15 nm and fluoresce in the near-infrared (NIR) spectrum. Nodal uptake of the entire thorax was imaged with a custom system that simultaneously acquired color video, NIR fluorescence of the QDs, and a merged picture of the two in real-time. Six pigs underwent right or left pleural space injection of QDs and similar imaging. MEASUREMENTS AND RESULTS: In the rat, the QDs drained solely to the highest superior mediastinal lymph node group, corresponding to lymph node station 1, according the regional lymph node classification for lung of the American Joint Committee on Cancer. In one rat, the injection of QDs in the left pleural space resulted in migration to the contralateral station 1 lymph node group. The injection of QDs in the right or left pleural space of the pig resulted in migration solely to the ipsilateral highest superior mediastinal lymph node group. CONCLUSIONS: NIR fluorescence imaging in two species demonstrated that the highest superior mediastinal lymph nodes of station 1 are the SLNs of the pleural space. This study also provides intraoperative feasibility and proof of the concept for identifying lymph nodes communicating with the pleural space on a patient-specific basis, in real-time, and with high sensitivity.
Authors: Sungjee Kim; Yong Taik Lim; Edward G Soltesz; Alec M De Grand; Jaihyoung Lee; Akira Nakayama; J Anthony Parker; Tomislav Mihaljevic; Rita G Laurence; Delphine M Dor; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni Journal: Nat Biotechnol Date: 2003-12-07 Impact factor: 54.908
Authors: Edward G Soltesz; Sungjee Kim; Rita G Laurence; Alec M DeGrand; Cherie P Parungo; Delphine M Dor; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni; Tomislav Mihaljevic Journal: Ann Thorac Surg Date: 2005-01 Impact factor: 4.330
Authors: D J Sugarbaker; J P Garcia; W G Richards; D H Harpole; E Healy-Baldini; M M DeCamp; S J Mentzer; M J Liptay; G M Strauss; S J Swanson Journal: Ann Surg Date: 1996-09 Impact factor: 12.969
Authors: D J Sugarbaker; G M Strauss; T J Lynch; W Richards; S J Mentzer; T H Lee; J M Corson; K H Antman Journal: J Clin Oncol Date: 1993-06 Impact factor: 44.544
Authors: Cherie P Parungo; Shunsuke Ohnishi; Alec M De Grand; Rita G Laurence; Edward G Soltesz; Yolonda L Colson; Peter M Kang; Tomislav Mihaljevic; Lawrence H Cohn; John V Frangioni Journal: Ann Surg Oncol Date: 2004-11-15 Impact factor: 5.344
Authors: Aaron M Mohs; Michael C Mancini; Sunil Singhal; James M Provenzale; Brian Leyland-Jones; May D Wang; Shuming Nie Journal: Anal Chem Date: 2010-10-06 Impact factor: 6.986
Authors: Cherie P Parungo; David I Soybel; Yolonda L Colson; Sang-Wook Kim; Shunsuke Ohnishi; Alec M DeGrand; Rita G Laurence; Edward G Soltesz; Fredrick Y Chen; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni Journal: Ann Surg Oncol Date: 2007-02 Impact factor: 5.344
Authors: Ruchi Sharma; Juliet A Wendt; John C Rasmussen; Kristen E Adams; Milton V Marshall; Eva M Sevick-Muraca Journal: Ann N Y Acad Sci Date: 2008 Impact factor: 5.691
Authors: W Matthew Leevy; Timothy N Lambert; James R Johnson; Joshua Morris; Bradley D Smith Journal: Chem Commun (Camb) Date: 2008-04-10 Impact factor: 6.222
Authors: Fiona A Murphy; Craig A Poland; Rodger Duffin; Khuloud T Al-Jamal; Hanene Ali-Boucetta; Antonio Nunes; Fiona Byrne; Adriele Prina-Mello; Yuri Volkov; Shouping Li; Stephen J Mather; Alberto Bianco; Maurizio Prato; William Macnee; William A Wallace; Kostas Kostarelos; Ken Donaldson Journal: Am J Pathol Date: 2011-06 Impact factor: 4.307